《Lancet》雜志的最新年發(fā)文量為218篇。
這表明該刊在每年都會精選并發(fā)表一定數(shù)量的高質(zhì)量文章,以保持其在醫(yī)學(xué):內(nèi)科領(lǐng)域的學(xué)術(shù)影響力。
該刊聚焦于醫(yī)學(xué)-醫(yī)學(xué):內(nèi)科領(lǐng)域的前沿研究,致力于推動該領(lǐng)域新技術(shù)和新知識的傳播與應(yīng)用。同時它積極鼓勵研究人員詳細(xì)發(fā)表其高質(zhì)量的實驗研究和理論成果。
該刊的平均審稿周期約為 約3月 。
Lancet 雜志發(fā)文統(tǒng)計
文章名稱引用次數(shù)
- Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 20171199
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017763
- Alcohol use and burden for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016735
- Food in the Anthropocene: the EAT-Lancet Commission on healthy diets from sustainable food systems718
- Hepatocellular carcinoma648
- Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017614
- Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial545
- Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries475
- Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial456
- Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017435
國家/地區(qū)發(fā)文量
- England1438
- USA1420
- CHINA MAINLAND437
- Australia408
- Canada393
- GERMANY (FED REP GER)341
- Switzerland331
- France277
- Netherlands238
- Italy234